DERM - CIK 0001867066
Journey Medical Corp trades as DERM. In its fiscal 2025 annual report the company posted revenue of $61.86M, up 10.2% from the prior year and net income of -$11.43M. This page tracks Journey Medical Corp through 210 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 5 fiscal years Journey Medical Corp's revenue grew from $44.53M to $61.86M, a compound annual growth rate of 6.8%. Net profit margin compressed from 11.9% to -18.5% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-13 |
| Major company event | 8-K | 2026-05-13 |
| SCHEDULE 13G | - | 2026-04-30 |
| Proxy materials | DEFA14A | 2026-04-30 |
| Proxy statement | DEF 14A | 2026-04-30 |
| Insider trade | 4 | 2026-04-24 |
| Insider trade | 4 | 2026-04-24 |
| Insider trade | 4 | 2026-04-24 |
The largest companies sharing Journey Medical Corp's SEC industry classification (pharmaceutical preparations).
Journey Medical Corp reported revenue of $61.86M for fiscal year 2025, an increase of 10.2% year over year.
In its latest fiscal year Journey Medical Corp reported a net loss of $11.43M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.